MGCLF / MGC Pharmaceuticals finalises plans for US clinical trial of CimetrA

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has provided clarity on the company's consolidation of capital and new fundraising programme. Fu more_horizontal

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said directors have been forced to propose a financial and capital restructuring plan to secure more_horizontal

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) hailed a "year of great productivity" as it pivoted to medicinal products, with legacy sales hit more_horizontal

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) said it is looking to raise up to A$2.7 million (£1.39 million) via a share purchase plan for more_horizontal

MGC Pharma said it has seen good momentum in its latest quarter with CannEpil, its Investigational Medicinal Product now available in the UK by Named more_horizontal

The era of cheap money is well and truly behind us. Nobody understands this more than the UK small caps, who are finding it increasingly harder and pr more_horizontal

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has raised £0.7mln (A$1.34mln) via a placing and subscription as well as a loan to bridge the c more_horizontal

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) confirmed that it is receiving an immediate downpayment of US$150,000 as part of last week's US$ more_horizontal